WASHINGTON, D.C. – The Trump administration’s response to the COVID-19 pandemic has been one of incompetence and inadequacy, from ignoring and downplaying the threat at the outset to its epic mismanagement and chaotic…
Read moreWASHINGTON, D.C. – President Trump’s Cabinet is “effectively sitting on the sidelines” during the coronavirus pandemic, according to a new report from NBC News, which finds that “many…
Read moreWASHINGTON, D.C. – The April jobs report is every bit the nightmare economists predicted, with 20.5 million falling out of the workforce and the unemployment rate more than tripling to 14.7…
Read moreWASHINGTON, D.C. – The latest Securities and Exchange Commission filings show at least 20 more publicly traded companies secured over $64 million in PPP funds. $3.5 million alone went to Sypris Solutions Inc.,…
Read moreWashington, DC – New reporting from the Associated Press reveals that the Trump administration is refusing to release guidance from top health experts at the CDC to help local…
Read moreNew analysis: Gilead could price remdesivir at $1 and STILL make a profit Gilead claims $1B in total development costs for remdesivir….less than what they paid out to shareholders in…
Read more**Read the new report HERE** Eli Lilly claim: “using all available resources” to fight coronavirus” → Eli Lilly reality: no increase in annual R&D from projections…additional $250M in revenue. Johnson…
Read moreWASHINGTON, D.C. – The U.S. economy continued its spiral toward a deep recession as 3.16 million more Americans filed for unemployment benefits this week, bringing the seven-week total…
Read moreGilead Q1 2020: $874M in cash dividends, $1.3B in stock buybacks, stock up 20% Gilead CEO cites responsibilities to shareholders, claims it’s “too premature” to speculate on COVID-19 profits REMINDER: Remdesivir discovered…
Read moreApril 27: Patients Over Pharma calls for Congress to protect HHS Inspector General from Trump bullying and intimidation May…
Read moreNew polling aligns with Patients Over Pharma’s push for Congress to prioritize drug affordability in upcoming COVID-19 legislation Only 9% believe Big Pharma claim that patient protections and affordability guarantees…
Read moreWASHINGTON, D.C. – Reporting in BuzzFeed revealed that a silicon valley engineer who obtained a $69.1 million contract to produce nearly 1,500 ventilators after tweeting at President…
Read more